With the aim of detecting mild dementias, 94 elderly subjects who had been participating in a long-term study since 1976 were studied by means of a new diagnostic instrument, the Alzheimer's Disease Assessment Scale (ADAS) (Rosen et al., 1984). Data available from intelligence tests performed during
Development of the Korean version of Alzheimer's Disease Assessment Scale (ADAS-K)
✍ Scribed by J. C. Youn; D. Y. Lee; K. W. Kim; J. H. Lee; J. H. Jhoo; K. U. Lee; J. Ha; J. I. Woo
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 102 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.699
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Objective
The purpose of this study was the development of the Korean Version of Alzheimer's Disease Assessment Scale (ADAS‐K).
Method
ADAS‐K was administrated to 84 AD patients as well as 105 non‐demented control subjects. Three aspects of reliability were tested. To evaluate the validity of ADAS‐K, discriminant validity and concurrent validity were tested. To evaluate the sensitivity of ADAS‐K to disease severity, all subjects, AD patients and control subjects, were grouped by CDR scale and their mean scores on ADAS‐K were compared.
Result
ADAS‐K demonstrated high levels of reliability. Mean ADAS‐K scores for AD patients were significantly different from the control group (p < 0.01). Furthermore, ADAS‐K exhibited significant correlations with other tests and scales (range 0.45–0.85, p < 0.01). In ROC curve analysis, ADAS‐K displayed high diagnostic efficacy and the optimal cut‐off point was selected between 18/19. ADAS‐K was able to discriminate the degree of AD severity according to CDR classification. Our results suggested that ADAS‐K‐cog was sensitive to very mild AD.
Conclusion
We demonstrated that ADAS‐K is a reliable and valid instrument not only for AD diagnosis but also for evaluation of its severity. Copyright © 2002 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract ## Objective The purpose of this study was to develop a Korean version of the behavior rating scale for dementia (BRSD‐K) for evaluating behavioral and psychological symptoms of dementia. ## Methods The BRSD‐K was administered to the informants of 268 subjects with dementia. Internal
A factor analysis of the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADASc), the primary cognitive outcome measure in most clinical trials of drugs for Alzheimer's disease, was undertaken to test whether factor scores are differentially sensitive to change in a placebo-controlled 30-wee
## Abstract ## Objectives The cognitive subscale of the Alzheimer's Disease Assesment Scale (ADAS‐Cog) is the most widely used test in clinical trials dealing with Alzheimer's disease (AD). The aim of this study was to investigate the validity and reliability of the Turkish version of ADAS‐Cog. #
## Abstract ## Objectives This study aims to examine the psychometric properties of the Chinese version of the Alzheimer's disease behavioral pathology rating scale (CBehave‐AD) and the behavioral profile of Chinese patients with AD. ## Methods Seventy‐one subjects with NINCDS‐ADRDA diagnosis of
## Abstract ## Background Both executive cognitive dysfunction and behavioral problems contribute to dysexecutive symptoms in daily life. The aim of the present study was to develop a behavior rating scale for assessing dysexecutive symptoms in Japanese patients with AD. ## Method The Dysexecuti